comparemela.com
Home
Live Updates
Promontory Therapeutics to Present Research on PT-112 in Prostate Cancer at the 34th EORTC-NCI-AACR Symposium : comparemela.com
Promontory Therapeutics to Present Research on PT-112 in Prostate Cancer at the 34th EORTC-NCI-AACR Symposium
/PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, today announced...
Related Keywords
Spain
,
United States
,
China
,
Germany
,
Canada
,
Zaragoza
,
Baja California
,
Mexico
,
Barcelona
,
Comunidad Autonoma De Cataluna
,
American
,
Ruth Soler Agesta
,
Mark Corbae
,
Stephanie Carrington
,
Taylorb Young
,
Promontory Therapeutics Inc
,
National Cancer Institute
,
University Of Zaragoza
,
Prnewswire Promontory Therapeutics Inc
,
American Association For Cancer Research
,
Merck Kga
,
Merck Kgaa
,
Serono
,
Virtual Congress
,
Strategic Development
,
Symposium Of The European Organisation For Research
,
Therapeutics Inc
,
European Organisation
,
American Association
,
Cancer Research
,
Presentation Session
,
Cell Biology
,
Promontory Therapeutic
,
Developmental Therapeutics
,
Orphan Drug
,
Promontory Therapeutics
,
comparemela.com © 2020. All Rights Reserved.